News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
488,104 Results
Type
Article (25431)
Company Profile (155)
Press Release (462518)
Multimedia
Podcasts (42)
Webinars (9)
Section
Business (141531)
Career Advice (749)
Deals (25515)
Drug Delivery (49)
Drug Development (54746)
Employer Resources (71)
FDA (12204)
Job Trends (10312)
News (236200)
Policy (19658)
Tag
Academia (1923)
Accelerated approval (4)
Adcomms (12)
Allergies (67)
Alliances (40496)
ALS (54)
Alzheimer's disease (1017)
Antibody-drug conjugate (ADC) (93)
Approvals (12233)
Artificial intelligence (263)
Autoimmune disease (13)
Automation (13)
Bankruptcy (211)
Best Places to Work (8910)
BIOSECURE Act (9)
Biosimilars (34)
Biotechnology (124)
Bladder cancer (62)
Brain cancer (22)
Breast cancer (185)
Cancer (1733)
Cardiovascular disease (126)
Career advice (660)
Career pathing (13)
CAR-T (135)
Cell therapy (362)
Cervical cancer (13)
Clinical research (44380)
Collaboration (733)
Compensation (229)
Complete response letters (10)
COVID-19 (1664)
CRISPR (42)
C-suite (189)
Cystic fibrosis (88)
Data (1801)
Decentralized trials (1)
Denatured (18)
Depression (29)
Diabetes (171)
Diagnostics (5630)
Digital health (17)
Diversity (4)
Diversity, equity & inclusion (19)
Drug discovery (103)
Drug pricing (48)
Drug shortages (19)
Duchenne muscular dystrophy (67)
Earnings (53961)
Editorial (20)
Employer branding (10)
Employer resources (62)
Events (70829)
Executive appointments (558)
FDA (13239)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (6)
Funding (620)
Gene editing (103)
Generative AI (25)
Gene therapy (265)
GLP-1 (359)
Government (2336)
Grass and pollen (3)
Guidances (48)
Healthcare (13294)
Huntington's disease (11)
IgA nephropathy (19)
Immunology and inflammation (56)
Indications (22)
Infectious disease (1771)
Inflammatory bowel disease (99)
Inflation Reduction Act (5)
Influenza (38)
Intellectual property (85)
Interviews (102)
IPO (12112)
IRA (22)
Job creations (1827)
Job search strategy (579)
Kidney cancer (8)
Labor market (13)
Layoffs (173)
Leadership (6)
Legal (3869)
Liver cancer (59)
Lung cancer (234)
Lymphoma (109)
Machine learning (6)
Management (21)
Manufacturing (227)
MASH (46)
Medical device (12229)
Medtech (12234)
Mergers & acquisitions (13921)
Metabolic disorders (418)
Multiple sclerosis (57)
NASH (10)
Neurodegenerative disease (57)
Neuropsychiatric disorders (8)
Neuroscience (1385)
NextGen: Class of 2025 (4516)
Non-profit (2336)
Now hiring (10)
Obesity (204)
Opinion (152)
Ovarian cancer (61)
Pain (68)
Pancreatic cancer (67)
Parkinson's disease (113)
Partnered (14)
Patents (209)
Patient recruitment (90)
Peanut (37)
People (40220)
Pharmaceutical (24)
Pharmacy benefit managers (6)
Phase I (15086)
Phase II (19801)
Phase III (14022)
Pipeline (971)
Policy (59)
Postmarket research (1106)
Preclinical (6275)
Press Release (67)
Prostate cancer (75)
Psychedelics (16)
Radiopharmaceuticals (215)
Rare diseases (303)
Real estate (3897)
Recruiting (28)
Regulatory (14850)
Reports (22)
Research institute (1828)
Resumes & cover letters (110)
Rett syndrome (5)
RNA editing (5)
RSV (29)
Schizophrenia (36)
Series A (115)
Series B (72)
Service/supplier (9)
Sickle cell disease (36)
Special edition (3)
Spinal muscular atrophy (138)
Sponsored (24)
Startups (2848)
State (2)
Stomach cancer (6)
Supply chain (47)
Tariffs (8)
The Weekly (22)
Vaccines (420)
Venture capitalists (21)
Weight loss (104)
Women's health (19)
Worklife (5)
Date
Today (131)
Last 7 days (654)
Last 30 days (2007)
Last 365 days (25719)
2025 (8221)
2024 (27756)
2023 (31971)
2022 (41701)
2021 (44364)
2020 (41673)
2019 (33923)
2018 (25190)
2017 (24659)
2016 (22998)
2015 (26789)
2014 (19773)
2013 (16207)
2012 (17281)
2011 (17843)
2010 (16345)
Location
Africa (460)
Alabama (42)
Alaska (6)
Arizona (140)
Arkansas (10)
Asia (32192)
Australia (6428)
California (4708)
Canada (1551)
China (395)
Colorado (215)
Connecticut (229)
Delaware (97)
Europe (64719)
Florida (736)
Georgia (155)
Idaho (36)
Illinois (378)
India (24)
Indiana (268)
Iowa (5)
Japan (143)
Kansas (85)
Kentucky (12)
Louisiana (8)
Maine (50)
Maryland (655)
Massachusetts (3521)
Michigan (197)
Minnesota (294)
Mississippi (2)
Missouri (68)
Montana (31)
Nebraska (20)
Nevada (52)
New Hampshire (67)
New Jersey (1376)
New Mexico (21)
New York (1342)
North Carolina (743)
North Dakota (8)
Northern California (2028)
Ohio (150)
Oklahoma (11)
Oregon (25)
Pennsylvania (1028)
Puerto Rico (11)
Rhode Island (26)
South America (714)
South Carolina (21)
South Dakota (1)
Southern California (1769)
Tennessee (72)
Texas (708)
United States (17899)
Utah (161)
Virginia (115)
Washington D.C. (28)
Washington State (488)
West Virginia (3)
Wisconsin (42)
488,104 Results for "genetic technologies limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change
Genetic Technologies Limited, a global leader in genomics-based tests in health, wellness and serious disease, announced its plans to effect.
December 12, 2023
·
2 min read
Bio NC
Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27
Genetic Technologies Limited is pleased to invite investors to a webinar on June 27, 2024, at 4:15 p.m. ET.
June 21, 2024
·
3 min read
Genetic Technologies Limited Announces Updated Investor Presentation
Genetic Technologies Limited (NASDAQ: GENE, ASX: GTG, “Company”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to provide an update on the company’s activities via the latest investor presentation attached.
August 9, 2023
·
2 min read
Genetic Technologies Announces $2 Million Registered Direct Offering
Genetic Technologies Limited announced that it has entered into a definitive agreement for the purchase and sale in a registered direct offering of 1,000,000 American Depositary Shares, each representing thirty ordinary shares of the Company, at a purchase price of $2.00 per ADS.
April 18, 2024
·
5 min read
Press Releases
Adial Pharmaceuticals Expands Intellectual Property Portfolio with New U.S. Patent Granted for Genetic-Based Treatment of Alcohol and Opioid Use Disorders
May 1, 2025
·
5 min read
Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering
Genetic Technologies Limited announces the closing of its previously announced registered offering for the purchase and sale of 1,000,000 American Depositary Shares, each representing thirty ordinary shares of the Company, at an offering price of US$2.00 per ADS.
April 22, 2024
·
5 min read
Press Releases
PacBio Technology Powers Landmark Multiomic Study Published in Nature Genetics
January 30, 2025
·
5 min read
Press Releases
Baylor Genetics Joins Child Neurology Society as Official Genetic Testing Partner
April 29, 2025
·
3 min read
Genetic Technologies’ Digital Strategy Ignites Significant Traction in US Market
Genetic Technologies Limited is pleased to report the company’s new digital strategy, led by the company’s recently appointed strategic advisor, Dr. Malcolm Bohm, is having a significant positive impact across all facets of GTG’s social media platforms.
April 2, 2024
·
4 min read
Press Releases
Myriad Genetics Partners with PATHOMIQ to add Artificial Intelligence Technology Platform to its Oncology Portfolio
February 25, 2025
·
6 min read
1 of 48,811
Next
